Every risk you treat ends in acceptance of what is left. Mitigation leaves a residual, insurance leaves exclusions, and walking away from an activity leaves the supplier you walked towards. Someone carries what remains.
This article is about who that someone is, what they sign, and what the signature has to have attached to it. The rest is arithmetic.
Four ways to treat a risk, and the one that is not a treatment
Once a risk has been identified and sized, the organisation decides what to do about it. NIST calls the stage Respond, ISO 31000 calls it risk treatment, and the short list below is the core the two share. NIST splits transfer into sharing part of the responsibility and liability and transferring all of it; ISO adds taking a risk on deliberately in order to pursue an opportunity.
| Response | What it does | What it does not do |
|---|---|---|
| Mitigate | Lowers likelihood or impact with controls | Remove the risk; a residual always remains |
| Transfer | Moves part of the financial loss to an insurer or supplier | Lower likelihood; move accountability; cover excluded losses |
| Avoid | Removes the source by stopping the activity | Come free; the activity’s benefit goes with it and a new dependency usually arrives |
| Accept | Carries the risk knowingly, on record | Last for ever; it expires with its review date |
Some study frameworks add deterrence as a fifth. Treat it as mitigation that only works on a person who fears the consequence, because it does nothing to a flood, a failed disk, or an automated attack, and budget for it accordingly.
The one behaviour that looks like a treatment and is not one is ignoring the risk. No owner, no record, no decision. The risk is carried exactly as it would be under acceptance, and the only difference is that nobody agreed to carry it. Regulators and courts tend to notice that difference. NIST’s managing information security risk guidance lists accept, avoid, mitigate, share and transfer as the responses available; leaving a known risk untouched with no record is not on the list.
Why the treatment decision is where the money moves
Everything before this point produces a ranked list of exposures. The treatment decision is where that list turns into spending: which risks get a control budget, which get a premium or a contract clause, which get an activity cancelled, and which get consciously carried.
Err one way and you buy controls that cost more than the loss they prevent. Err the other way and you carry a risk nobody with authority agreed to carry. The second error is the harder one to see, because until the loss lands nothing looks wrong, and then it arrives with a question about who decided.
The treatment decision also fixes accountability. Every accepted risk needs an owner with the authority to accept it. Every transferred risk still needs one, because the regulator and the customer come to you, not to your insurer. A treatment with no owner is not a decision. It is a hope with a line item.
What cyber insurance buys, and what it cannot
Insurance is the example every framework reaches for when it explains transfer, so it is worth being precise about. A policy typically indemnifies the costs that follow an incident: forensic investigation, legal advice, customer notification, business interruption, and liability to third parties. Three limits decide whether it is worth what you pay for it.
- The policy itself prevents nothing. Likelihood only changes if the cover comes with services that change your controls, and some does. That is why insurers commonly require minimum controls as a condition of cover, and the NCSC’s cyber insurance guidance is blunt that a policy is no substitute for them. In practice, transfer arrives bundled with mitigation you would have had to buy anyway.
- It does not move accountability. The organisation remains the party the regulator fines, the customer sues, and the board answers for. Data protection law makes the same point about suppliers: the ICO’s accountability guidance keeps the controller responsible for what its processors do.
- It has edges. Exclusions for state-sponsored action, for known and unpatched vulnerabilities, and for fines the law does not permit to be insured are common. Sub-limits cap the payout for the categories you most expect to claim on. The loss you most fear is often the one nearest an edge.
Outsourcing behaves the same way. A contract can shift the operational work and some of the financial exposure to a provider. It cannot shift your duties to the people whose data you hold.
Acceptance versus quietly ignoring it
Acceptance is a legitimate and frequent response. It is the right one when the residual sits within risk appetite, when treating the risk would cost more than the loss it prevents, or when no treatment exists and the activity has to continue. What separates it from ignoring the risk is not the outcome, since in both cases the risk is carried. It is the presence of five things.
| Carrying a risk | Owner with authority | Written rationale | Register entry | Review date | Visible to senior management |
|---|---|---|---|---|---|
| Acceptance | Present | Present | Present | Present | Present |
| Ignoring it | Absent | Absent | Absent | Absent | Absent |
A risk register entry with no owner and no review date, whose only note is an engineer’s remark from two years ago that it is unlikely to be exploited, is a risk being ignored. The label does not change that. Acceptance is the record that due care requires, and its value is precisely that it can be read back later by someone who was not in the room. The record does not make a poor decision a good one. It makes the decision visible, which is the precondition for anyone correcting it.
A treatment sequence that survives an audit
No standard prescribes an order, but a repeatable sequence keeps the decision defensible and stops the team defaulting to whichever option was easiest to budget.
1. Size it residual loss against appetite
|
2. Avoid? can the activity stop without losing more than the risk costs
|
3. Mitigate? is there a control that saves more than it costs
|
4. Transfer? is the residual financial loss insurable or contractable
|
5. Check it worked is the residual now inside appetite? if not, go round again
|
6. Accept the rest owner, rationale, register, review date, visibility
Steps 5 and 6 are not optional. A treatment is not finished until someone has confirmed it did what the business case said, and every treated risk ends in an acceptance of its residual, so every risk on the register should carry an acceptance record even when the headline response was mitigation.
An illustration, with invented figures. An online retailer runs its own checkout page and sizes the risk of card-skimming script at an expected loss of forty thousand a year against an appetite of fifteen thousand for any single risk of that kind. Accepting it as is fails the first test. Avoidance, by moving card capture to the payment provider’s hosted page, removes the source of the highest-impact loss and shrinks the compliance scope with it, at the cost of a new supplier dependency. Mitigation on the rest of the page, through script integrity checks and alerting, saves more than it costs. A policy is then priced against the much smaller residual rather than the original exposure. What is left is accepted, by name, with a twelve-month review at which the new supplier dependency is assessed as a risk in its own right.
Notice that no step moved accountability. In every option it stayed with the retailer. The NIST guide for conducting risk assessments is where the sizing in step 1 comes from, and it is the only step that needs a spreadsheet.
Where risk treatment decisions go wrong
- Calling it acceptance when it is neglect. No owner, no rationale, no register entry, no review date. The word in the minutes is not the decision.
- Believing the premium bought accountability. It bought part of the financial loss. Everyone who can hurt you still knows your address.
- Buying the control regardless of cost. A mitigation that costs more per year than the loss it removes fails the cost test, and unless something other than money is at stake, a legal duty, a contractual promise, harm to people, or a loss the organisation could not survive, that should end the argument. The disciplined answer may be to accept or to transfer, and saying so is not a failure of nerve.
- Treating avoidance as free. Stopping an activity forgoes its benefit and usually creates a dependency or a new risk, which then needs its own entry.
- Deterring the wrong threat. Banners and sanctions change a person’s decision. They do nothing to a remote, automated attacker.
- Acceptance with no expiry. The threat changes, the asset changes, the signatory leaves. A review date is part of the decision, not an afterthought.
- The signature at the wrong level. A risk accepted by someone without the authority to carry the loss, whether that authority comes from budget or from responsibility for the business it sits in, has been accepted by nobody.
Questions to ask before you sign an acceptance
- Whose budget absorbs this loss if it happens, and is that the name on the form?
- What would it cost per year to mitigate, and is that more or less than the loss it would remove?
- If we transferred it, what is excluded, what is sub-limited, and what controls does the insurer require us to have anyway?
- If we avoided it, what benefit do we give up and what new dependency do we take on?
- When does this acceptance expire, and who is responsible for the review?
- Has anyone above the signatory seen it, or will the board first hear of this risk on the day it lands?
Start here. Pull the risk register and mark every entry that is being carried without an owner, a rationale, and a review date, because each one is a risk being ignored under a politer name.
A risk you have not decided about has been decided about. You just were not in the room.